scholarly journals Remédios genéricos no mercado farmacêutico – a importância do medicamento genérico para a sociedade / Generic drugs in the pharmaceutical market - the importance of generic drugs for a society

2021 ◽  
Vol 4 (6) ◽  
pp. 25828-25843
Author(s):  
Antilde José Gomes Júnior ◽  
Maria Eliete Oliveira Fonseca ◽  
Renelton da Silva Batalha ◽  
Renato Bruno Silva Machado ◽  
Anne Cristine Gomes de Almeida
Keyword(s):  
Generic Drugs ◽  
Pharmaceutical Market

Generic Drugs in the Pharmaceutical Market

2016 ◽  
pp. 443-468
Author(s):  
Mercedes Rozano
Keyword(s):  
Generic Drugs ◽  
Pharmaceutical Market ◽  
National Brands ◽  
Product Categories ◽  
Pharmaceutical Expenditures ◽  
Market Shares ◽  
Generic Market ◽  
Packaged Foods ◽  
Generic Products

Over the past three decades, marketing has increased its interest in studying the role of generic products in the pharmaceutical sector, one that has only recently incorporated the concept of “generic” products, compared to others such as the mass market. Since the emergence of generic products as one of national brands' main competitors, these have shown significant growth in both their market share, as well as in new product categories. Initially, the concept of generic products was limited to categories of packaged foods and later extended to categories such as medicine. Pharmaceutical market presents an opportunity to analyze the expansion of the “generic” concept, in a strongly regulated framework. In Europe, different policies have resulted in a varying development of generic market shares. Today, the sustainability of health system is a matter of increasing concern to European governments. Generic drugs offer an opportunity to contain pharmaceutical expenditures, since generic price are lower than their original brand equivalent. Developing this market is the main objective.

scholarly journals Export Potential of the Russian Pharmaceutical Market and its Prospects

2018 ◽  
Vol 7 (4.38) ◽  
pp. 1214
Author(s):  
Natalia Pyatigorskaya ◽  
Andrei Meshkovski ◽  
Zhanna Aladysheva ◽  
Valery Beregovykh ◽  
Vasily Belyaev ◽  
...  
Keyword(s):  
International Cooperation ◽  
Generic Drugs ◽  
Import Substitution ◽  
The State ◽  
Pharmaceutical Market ◽  
Regulatory Mechanisms ◽  
Pharmaceutical Sector ◽  
Substitution Policy ◽  
Innovative Drugs ◽  
Policy Targets

Export of medicines is one of the most profitable businesses, which attracts the attention of an increasing number of producers. The international medicines’ trade largely depends on national or regional regulatory mechanisms. In addition, the export terms and conditions differ for various categories of medicines. Innovative drugs account for the main share of the global medicines’ export. Therefore, export of innovative drugs developed in Russia to advanced countries is the most economically profitable direction. Export of generic drugs can bring considerable revenue to the producer and the state, but import substitution by releasing generic drugs weakens the innovative direction of studies and production. The import substitution policy targets manufacturers of medicines to produce generic drugs, as well as products intended, mainly or exclusively, for sale within the country. One of the ways to improve the efficiency of the entire pharmaceutical sector is international cooperation.  

Middle East generics: Challenges & opportunities

2012 ◽  
Vol 9 (1) ◽  
pp. 13-20 ◽  
Author(s):  
Mazen Tantash
Keyword(s):  
Saudi Arabia ◽  
Middle East ◽  
Generic Drugs ◽  
Pharmaceutical Market ◽  
Policy Makers ◽  
The World ◽  
New Policies ◽  
Growing Population

The pharmaceutical market in the Middle East is valued at more than $9.4b and is expected to grow over at a rate of 10% annually. Although there continues to be unrest in the region and around the world, both economically and politically, the Middle East has seen a shift and the pharmaceutical market is becoming more attractive. These countries are traditionally high importers of originator brands and branded generic drugs. Although originator drugs have previously held most of the market, new policies that favor generics are being implemented in the region. The pharmaceutical market ranges quite a bit within the various countries in the Middle East, Bahrain remains the smallest market with Saudi Arabia being the largest due to a growing population and new westernized lifestyle. Policy makers in the region should continue to encourage new players by continuing to propose new policies that allow for continued growth

scholarly journals ДОСЛІДЖЕННЯ СТАНУ ОРГАНІЗАЦІЇ ЗАБЕЗПЕЧЕННЯ НАСЕЛЕННЯ ЛІКАРСЬКИМИ ЗАСОБАМИ В РОКИ НЕЗАЛЕЖНОСТІ УКРАЇНИ -СТАНОВЛЕННЯ ФАРМАЦЕВТИЧНОГО РИНКУ

2015 ◽  
Author(s):  
V. O. Boryshchuk ◽  
O. S. Solovyov ◽  
T. M. Krasnianska ◽  
I. V. Klymenko ◽  
S. V. Auhunas ◽  
...  
Keyword(s):  
Large Scale ◽  
Generic Drugs ◽  
Pharmaceutical Market ◽  
Small Scale ◽  
Regulatory Requirements ◽  
Drug Molecules ◽  
Market Formation ◽  
Pharmaceutical Activity ◽  
The Law ◽  
Methods Analytical

<p>The aim of the research was to study the correspondence of existing legislative and regulatory requirements of the pharmaceutical industry development, the analysis of the formation of the Ukrainian pharmaceutical market, the condition of drug assistance according to European requirements and recommendations of the WHO.</p><p>For the study archival materials, publications in scientific journals, and mass media were used, laws and provisions regulating pharmaceutical activity were studied and a survey among citizens was conducted. Systematic and logical methods, analytical and comparative analysis were applied, and own researches were performed.</p><p>For 22 years of Ukrainian statehood formation the following institutes were created: Pharmacological College, Pharmacopoeia Committee and State Service for Quality Control of Drugs which were transported to other institutes. Important laws were adopted: the Law of Ukraine «On Medicines», the Law of Ukraine «On small-scale privatization», the Law of Ukraine «On large-scale privatization» and others, which contributed to the formation and development of the pharmaceutical market.</p><p>In comparison with 1990 the amount of drugstore chains increased two and a half times and in 2013 in the country already worked 15 566 drugstores, including 3 025 in villages. Specific peculiarity of pharmaceutical market formation in Ukraine was the creation of powerful own regional and all-Ukrainian drugstore chains, that is greatly different from such situation in EU countries, where the legislation allows to have only one or two drugstores. As the result of pharmaceutical market formation the drugs nomenclature increased eight times and now makes up more than 20 000 names, including 92.4 % generic drugs. According to publications, Ukraine lacks about 40 % of drug molecules needed for medical treatment, and 30 % of studied drugs are not proved. There is the problem of uncontrollable turnover and drugs consumption in Ukraine. Self-treatment is widespread today: 82 % of Ukrainians prescribe medicines by themselves even when they feel a little unwell.</p><p>Among all examined 75 drugstores in different regions (Zakarpattya, Rivne, Khmelnytsk, Kherson etc.) people can get drugs without prescription. During 2014 the pharmaceutical market in comparison with previous year rose by 14 % and its income made up 36 billion UAH. Drug producers perform aggressive marketing and break rules of drugs advertising. Among important problems that require the improvement of legislative and regulatory base at governmental level concerning the economic drug assistance for all population groups.</p>

scholarly journals DEVELOPMENT OF RUSSIAN PHARMACEUTICAL MARKET IN CONDITIONS OF CORONAVIRUS INFECTION SPREAD

2021 ◽  
Vol 10 (34) ◽  
Author(s):  
V.S PROSALOVA ◽  
◽  
O.V GETMAN ◽  
M.A FALALEEV ◽  
N.A SITDIKOVA ◽  
...  
Keyword(s):  
Generic Drugs ◽  
Poor Quality ◽  
Pharmaceutical Market ◽  
Production Costs ◽  
Public Authorities ◽  
Global Trends ◽  
The Public ◽  
Term Basis ◽  
Specific Factors ◽  
High Level

The pharmaceutical market is a socially significant production, and therefore subject to strict control by the public authorities of all countries. At the same time, the pharmaceutical market is one of the most promising areas for investors, as one of the most profitable today. All these factors lead to close attention to the drug industry by both economists, pharmacists, and doctors. The domestic pharmaceutical market experienced some difficulties before the spread of the pandemic, which has been aggravated to date. In this regard, it is necessary to analyze the trend of the pharmaceutical market of Russia today, to identify the factors that have the greatest impact on its development. The main factors that are characteristic of other industries are: the high level of production costs, the difficulty of attracting investors on a long-term basis, and high global competition. Specific factors include: the poor quality of finished dosage forms and pharmaceutical substances, an outdated product range and the predominance of generic drugs, a small amount of branded products. The presented article presents an analysis of the latest trends in the domestic pharmaceutical market, highlights global, global trends that have an impact on it.

scholarly journals Choice of mandatory prescribed drugs in Portugal: a consumers’ perspective

2017 ◽  
Vol 11 (4) ◽  
pp. 439-454 ◽  
Author(s):  
Pedro Ferreira ◽  
Hugo Barbosa
Keyword(s):  
Decision Making ◽  
Perceived Risk ◽  
Purchase Intention ◽  
Generic Drugs ◽  
Cross Sectional Study ◽  
Pharmaceutical Market ◽  
Main Hypothesis ◽  
Cross Sectional ◽  
Content Type ◽  
Price Consciousness

Purpose This paper aims to contribute to the understanding of what influences consumers’ choice of mandatory prescribed drugs, by looking with more detail to the substitution of branded drugs by generics. Specifically, this research looks at three factors that can influence this decision, namely, participative decision-making, perceived risk and price consciousness, within the recent changes introduced in the Portuguese pharmaceutical market by new legislation. Design/methodology/approach A cross-sectional study was conducted, using a self-administered questionnaire, to survey a sample of consumers/patients that visited a doctor and were prescribed some kind of drug. Data were treated using factor analysis for dimensionality reduction purposes and regression analysis to test the main hypothesis. Findings The results show that participative decision-making has no impact on purchase decision of generics, while perceived risk and price consciousness show a predictive power regarding purchase intention of generic drugs. Research limitations/implications Although the results are only applicable to the Portuguese context, it draws important conclusions regarding consumers’ behaviour when choosing between branded and generic drugs. Practical implications Knowing what influences consumers’ choices of generic drugs contributes to tune marketing strategies and actions. For public institutions, this paper offers insights on how to adapt public policies. Originality/value This paper is valuable because it is the first to look at the Portuguese pharmaceutical market from a consumer behaviour perspective since new legislation was set up.

scholarly journals PHARMACEUTICAL MARKET AND OPPORTUNITY IN THE 21ST CENTURY FOR GENERIC DRUGS: A BRAZILIAN CASE STUDY OF OLANZAPINE

2013 ◽  
Vol 6 (1) ◽  
pp. 31-39
Author(s):  
Jorge Lima de Magalhães ◽  
Luc Quoniam ◽  
Núbia Boechat
Keyword(s):  
Pharmaceutical Industry ◽  
Generic Drugs ◽  
Innovation Management ◽  
Developing Nations ◽  
Pharmaceutical Market ◽  
Competitive Intelligence ◽  
Bibliographical Survey ◽  
Official Data ◽  
Total Market

This paper aimed to identify and analyse the evolution of the generic pharmaceutical market in Brazil, specifically olanzapine drugs. For this purpose, it has been demonstrated trends through access free tools. By bibliographical survey in indexed databases as well as official data in Brazil for generic drugs and public policy, it was analyzed and performed a case study . In 2012, global pharmaceutical industry surpassed US$ 950 billion in sales with trend to reach US$ 1,2 trillion by 2016. In Brazil market has grown in its global ranking, jumped from 10th place to 7th place in five years and projection it’ll stay Top five by 2015. Brazil has significant presence in pharmerging markets by increasing US$ 10 billion/year. Generics segment accounts approximately to 20% of the total market. 2003-2011 registered a growth of 42.3%. Patents expiration in the neuroleptics area becomes more promising like a market of olanzapine in the last eight years is around US$ 120 million. After the end of the olanzapine patent (2011) sales increased 270% which demonstrate potential Brazilian market in this new century. Management problems for developing nations and undeveloped such as network management and patents analysis for health care might reveal great opportunities for investors, e.g., creation of the Big Brazilian biotechnology pharmaceutical industry. Keywords: competitive intelligence, pharmaceutical trends, technological and innovation management.

scholarly journals FEATURES OF THE RUSSIAN PHARMACEUTICAL MARKET

2021 ◽  
Vol 10 (34) ◽  
Author(s):  
A.I OVOD ◽  
Keyword(s):  
National Security ◽  
Generic Drugs ◽  
Import Substitution ◽  
Pharmaceutical Products ◽  
Pharmaceutical Market ◽  
The Past ◽  
Technical Potential ◽  
The Cost ◽  
Total Sales

The pharmaceutical market in Russia in the current environment is one of the most dynamically developing, which is associated with its high importance for ensuring national security. The change in the foreign policy environment against the background of the events of 2014 showed the negative aspects of the country's previously existing dependence on the import of pharmaceutical products, defining the implementation of the import substitution strategy in the field of drug supply as a long-term benchmark for the development of the industry. However, its implementation actually ran into a number of difficulties, the most important of which is the insufficient level of development of the country's scientific and technical potential in this industry. In the course of the study, the analysis of the main indicators of the dynamics and structure of the domestic pharmaceutical market in physical and value terms, identification of the main trends and their causes was carried out. It has been established that in the past 3 years the domestic pharmaceutical market has been developing, which is confirmed by a steady trend towards an increase in its value from 1.6 to 1.8 trillion. rub. At the same time, generic drugs predominate in the market structure in 2019, accounting for more than 85% of the total number of packs sold, the cost of which amounted to about 60% of the total sales. Consequently, on the Russian pharmaceutical market, there is a tendency towards active distribution of generic drugs of domestic origin, which is due to their price advantage compared to original imported drugs, which are expensive and have problems with implementation under conditions of economic sanctions.

Generic Drugs in the Pharmaceutical Market

2019 ◽  
pp. 1236-1261
Author(s):  
Mercedes Rozano
Keyword(s):  
Generic Drugs ◽  
Pharmaceutical Market ◽  
National Brands ◽  
Product Categories ◽  
Pharmaceutical Expenditures ◽  
Market Shares ◽  
Generic Market ◽  
Packaged Foods ◽  
Generic Products

Over the past three decades, marketing has increased its interest in studying the role of generic products in the pharmaceutical sector, one that has only recently incorporated the concept of “generic” products, compared to others such as the mass market. Since the emergence of generic products as one of national brands' main competitors, these have shown significant growth in both their market share, as well as in new product categories. Initially, the concept of generic products was limited to categories of packaged foods and later extended to categories such as medicine. Pharmaceutical market presents an opportunity to analyze the expansion of the “generic” concept, in a strongly regulated framework. In Europe, different policies have resulted in a varying development of generic market shares. Today, the sustainability of health system is a matter of increasing concern to European governments. Generic drugs offer an opportunity to contain pharmaceutical expenditures, since generic price are lower than their original brand equivalent. Developing this market is the main objective.

Sign in / Sign up

Export Citation Format

Share Document